Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,055.00    30.00 (0.50%)
Bid:
6,050.00
Ask:
6,060.00
Spread: 10.00 (0.165%)
Market Cap: £5.17b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

8 Feb 2022 07:00

RNS Number : 9482A
DCC PLC
08 February 2022
 

 

8 February 2022

Board Changes

 

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Mr. Alan Ralph as Chairman of its Audit Committee with effect from 31 March 2022, succeeding Ms. Jane Lodge who will retire as a Non-Executive Director and as Chairman of the Audit Committee on the same date.

Mr. Ralph, who joined the Board in November 2021, is an experienced business and finance leader having spent 20 years with UDG Healthcare plc (formerly United Drug plc). Mr. Ralph spent ten years leading UDG's largest business unit before supporting its strategic transformation as Chief Financial Officer for five years. Mr. Ralph is a Chartered Accountant.

Mark Breuer, Chairman of DCC plc, said:

"I welcome Alan Ralph as Chairman of the Audit Committee. His financial expertise and business leadership experience will stand the Committee in good stead as DCC continues to grow.

I would also like to thank Jane Lodge for her significant contribution to our Board and Audit Committee over almost ten years. "

Contact information

Investor enquiries:

 

Darragh Byrne, Company Secretary

Tel: +353 1 2799 400

Rossa White, Head of Group Investor Relations

Email: investorrelations@dcc.ie

 

 

Media enquiries:

 

Powerscourt (Eavan Gannon/Genevieve Ryan)

Tel: +44 20 7250 1446

 

Email: DCC@powerscourt-group.com

DCC website:

 

www.dcc.ie

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on sustainable growth. DCC is an ambitious and entrepreneurial business operating in 21 countries, supplying products and services used by millions of people every day. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

Headquartered in Dublin, the Group operates across three sectors: energy, healthcare and technology, employing approximately 15,000 people. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue of £13.4 billion and operating profit of £530.2 million.

DCC has an excellent record, delivering compound annual growth of 14% in operating profit and generating an average return on capital employed of approximately 19% over 27 years as a public company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATRMPTMTIMBMT
Date   Source Headline
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20255:42 pmRNSResult of AGM
10th Jul 20257:00 amRNSAGM Trading Statement
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20253:11 pmRNSHolding in Company TR-1
11th Jun 202510:00 amRNS2025 Annual Report, Notice of AGM and Proxy Form
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20255:20 pmRNSTotal Voting Rights
30th May 20255:00 pmRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSLaunch of £100 million Share Buyback Programme
23rd May 20255:10 pmRNSDirector/PDMR Shareholding
13th May 20257:00 amRNSResults for the year ended 31 March 2025
22nd Apr 20257:00 amRNSDisposal of DCC Healthcare
9th Apr 20257:00 amRNSDCC Leadership Changes
28th Feb 202511:00 amRNSTotal Voting Rights
5th Feb 20257:00 amRNSQ3 Trading Statement
9th Dec 202412:23 pmRNSDirector Declaration
29th Nov 20242:33 pmRNSTotal Voting Rights
18th Nov 20245:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.